Inventor · disambiguated record
Fangfang Jin
Also filed as: JIN FANGFANG
4 granted patents·4 pending applications·5 citations·filing 2014–2025
60Inventor score
Files withSHANGHAI HANSOH BIOMEDICAL CO LTD4JIANGSU HENGRUI MEDICINE CO2Shanghai hengrui pharmaceutical co ltd2
Top patents by PatentIndex Score
8 records- 0176US9637484B2Cycloalkyl acid derivative, preparation method thereof, and pharmaceutical application thereofShanghai hengrui pharmaceutical co ltd·Filed 2014·Granted May 2, 2017·5 cites·20 claims
- 0260US12497366B2Nitrogen-containing heterocyclic derivative inhibitor, preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2025·Granted Dec 16, 2025·0 cites·15 claims
- 0358US2021230138A11,2,4-triazine-3-amine derivative, preparation method therefor, and use thereof in medicineJIANGSU HENGRUI MEDICINE CO·Filed 2021·Application pending·0 cites
- 0457US2025059196A1Tricyclic derivative inhibitor, preparation method therefor, and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 0555US2025066360A1Pyridine-containing polycyclic derivative, and preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2023·Application pending·0 cites
- 0654US2025388578A1Nitrogen-containing heterocyclic derivative inhibitor, and preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2025·Application pending·0 cites
- 0753US11014904B21,2,4-triazine-3-amine derivative, preparation method therefor, and use thereof in medicineJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted May 25, 2021·0 cites·14 claims
- 0833US10081629B2Amide derivatives and pharmaceutically acceptable salts thereof, preparation method thereof and medicinal application thereofShanghai hengrui pharmaceutical co ltd·Filed 2015·Granted Sep 25, 2018·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Fangfang Jin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →